Section Arrow
Quote
KVUE.NYSE
- Kenvue
Quotes are at least 15-min delayed:2026/11/14 14:25 EST
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
19.31 
1-M High
20 
Volume 
-- 
Bid
--
Ask
--
Day Low
-- 
Open
-- 
1-M Low
17.54 
Market Cap 
37.11B 
Currency 美元 
P/E 22.72 
%Yield 5.4 
10-SMA 19.38 
20-SMA 18.64 
50-SMA 18.41 
52-W High 20.13 
52-W Low 15.94 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.88/1.22
Enterprise Value
44.27B
Balance Sheet
Book Value Per Share
5.29
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
15.44B
Operating Revenue Per Share
8.03
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SLSNSolesence Inc1.52+0.611+67.22%94.05PE
COTYCOTY4.04+0.01+0.25%-- 
PGProcter & Gamble Company169.8+1.77+1.05%25.29PE
CLColgate-Palmolive Company99.67+1.77+1.81%38.06PE
KMBKimberly-Clark Corp109.43+2.24+2.09%20.52PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, includingTylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.